/Companies

Genomelink

YC S21

San Francisco, US · Founded 2017 · 15 employees · 18 known investors

Find your way into Genomelink

Sign up to see every warm intro you have to Genomelink

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Genomelink team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Genomelink develops a platform that provides individuals with access to and management of their genomic data, leveraging advances in DNA sequencing technology. The company serves consumers seeking personal genetic information and operates in the genomics and digital health sector.

Also known as Genomelink

Founders & leadership· Y Combinator alumni (S21)

Genomelink was founded in 2017 by Tomohiro Takano, Kensuke Numakura, Takamasa Kudo, and Yuta Matsuda.

TTTomohiro Takano
Tomohiro TakanoCo-founder · CEOFounder and CEO of Genomelink, a platform that provides individuals access to and management of their genomic data.
KNKensuke Numakura
Kensuke NumakuraCo-Founder and CTOKensuke Numakura is co-founder and CTO of Genomelink.
TK
Takamasa Kudo
YMYuta Matsuda
Yuta MatsudaCo-founder COO2017–2025

Investors · 18

500 Globallisted by 500 GlobalPalo Alto · $150K

How we know: open dataset · 500 Global portfolio 2026-08 · Not right? Tell us

Metaplanetlisted by MetaplanetTallinn · $500K – $10M

How we know: Metaplanet's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Novogenia GmbHlisted by Novogenia GmbH

How we know: Y Combinator's founder network · Not right? Tell us

Berkeley SkyDeck FundreportedBerkeley · $200K

How we know: Y Combinator's founder network · Not right? Tell us

Global BrainreportedTokyo · $100K

How we know: Y Combinator's founder network · Not right? Tell us

Ironfire Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

SAV (Scale Asia Ventures)reportedPalo Alto

How we know: Y Combinator's founder network · Not right? Tell us

Company profile

researched Aug 2026

Genomelink operates a consumer-facing website where individuals upload raw DNA data files produced by other consumer genetic testing providers, including AncestryDNA, 23andMe and MyHeritage, and receive additional analyses generated from that file. The service is positioned as a way to extract further insight from a DNA test a customer already purchased, rather than as a testing laboratory itself; guidance material on the site explains how to download raw DNA data from Ancestry, 23andMe and MyHeritage.

The report catalogue spans several categories. Ancestry products include deep and global ancestry breakdowns covering more than 160 ethnicities and roughly 2,000 community-level breakdowns, regional modules for the British Isles and UK, Europe, Asia and Africa, Native American heritage across ten regional groups, Y-DNA paternal lineage, and ancient-DNA comparisons such as Viking and Nordic matching against 500+ ancient individuals, Celtic, Iberian, Greek, Italian and ancient European bloodlines, hunter-gatherer versus farmer proportions, and Neanderthal and Denisovan ancestry. A second group of reports covers wellness and lifestyle topics, including nutrition and nutrigenomics, fitness, skincare, mental wellbeing, organ and joint/blood wellness, plus trait reports on personality, physical characteristics, sports performance and cognitive traits. The site also publishes an editorial blog reviewing and comparing consumer DNA testing and genealogy tools.

Business model

Genomelink offers a free entry point — users can upload an existing DNA file and receive 100 free traits with no credit card required — alongside a broader catalogue of specialised ancestry and wellness reports accessed through the same account.

Latest developments

The site lists DNA Matches as a new feature alongside its deep ancestry and free trait offerings.

▸Full profile — market position, technology, go-to-market

Market position

The company positions its reports as unavailable elsewhere, emphasising depth beyond a basic ethnicity estimate — regional and ancient ancestry, nutrition and wellness insights — derived from a DNA file the customer already owns, and cites ISO 27001 certification.

Technology

Analyses are computed from uploaded raw genotype files. The company describes deep ancestry results as produced by advanced statistical models with scientific reliability scores, and chromosome-level analysis across all 22 autosomes for its global, European and Native American breakdowns. Several modules are described as co-developed with Stanford, including use of the Stanford-developed XGMix method for the Asian breakdown, while the UK breakdown is described as co-developed with Living DNA. Ancient-ancestry reports compare user genomes against curated ancient DNA sample sets, such as 600+ ancient genomes for the Americas, 500+ Viking-age and earlier individuals, and 200+ samples each for Celtic, Iberian and Italian ancestry.

Go-to-market

Direct-to-consumer acquisition through the company's website, with a free trait offer as the onboarding hook and a content marketing blog covering DNA upload sites, DNA test reviews and how-to guides on raw data.

Consumers who have already taken a direct-to-consumer DNA test with providers such as AncestryDNA, 23andMe or MyHeritage and want additional ancestry, trait or wellness interpretation of that data.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Ethnicities covered in Deep Ancestry reportFeb 2026160 ethnicities
Free trait reports offered on DNA uploadFeb 2026100 reports
HeadcountAug 202613
ISO 27001 certificationFeb 2026ISO 27001 Certified

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 10

TriomicsTriomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation. The company serves oncology clinics, trial matching networks, and quality reporting teams.
23andMe23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.
CurebaseCurebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites. The platform emphasizes modern technology, data integrity, and compliance for advancing medical research.
MyheritageMyHeritage operates an online genealogy service where users build family trees, search historical records, and connect with relatives. It also offers DNA testing to help people trace ancestry and identify biological relationships.
MicrohealthMicrohealth builds digital tools that connect patients with healthcare professionals outside clinical settings to improve treatment outcomes and enable patient engagement. The company serves patients, healthcare professionals, patient organizations, and medical organizations across specialty care.
SequencingSequencing.com offers free storage of personal DNA data along with tools and reports that turn genetic testing results into health-related insights for consumers. The company addresses data storage, usability, and privacy challenges created by widely available consumer genetic testing.
GamgeeGAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
54Gene54Gene conducts genomics research and provides related services to increase the representation of African genetic data in medical research, which aims to advance healthcare solutions globally.
Nebula GenomicsNebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA. Its DNA Complete product delivers 350+ personalized genetic reports across categories such as cardiovascular health, brain health, and wellness.
Self DecodeSelfDecode is a consumer genomics platform that analyzes users' DNA, blood test results, and lifestyle data to generate 1,500+ personalized health reports and AI-driven recommendations on diet, supplements, and lifestyle. It sells DNA test kits and subscription access to tools including an AI health assistant (DecodyGPT) and lab analysis, serving consumers, doctors, and businesses.

Companies working in the same space as Genomelink.

Legal entities · 1

corporate structure
Genomelink, Inc.

▸Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Genomelink do?
Genomelink is a DNA upload service that turns existing consumer DNA test files into ancestry, trait and wellness reports.
Who founded Genomelink?
Genomelink was founded by Tomohiro Takano, Kensuke Numakura, Takamasa Kudo, Yuta Matsuda in 2017.
Who are Genomelink's investors?
Genomelink's investors include 500 Global, Brighter Capital, Coral Capital, DG Daiwa Ventures, Lair East Labs, LifeX Ventures, Metaplanet, Novogenia GmbH and 10 more.
Where is Genomelink headquartered?
Genomelink is headquartered in San Francisco, US.